Sunshine Biopharma, Inc.
SBFMNASDAQHealthcare● Active
$2.43
$-0.03(-1.22%)
Market Cap$1216409
P/E Ratio—
52W High$24.3
52W Low$2.11
Sunshine Biopharma, Inc. (SBFM) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · SBFM · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $36.31M | $34.87M | $24.09M | $4.35M | $0.23M |
| Cost of Revenue | $24.38M | $24.20M | $15.75M | $2.65M | $0.12M |
| Gross Profit | $11.92M | $10.67M | $8.34M | $1.70M | $0.11M |
| Gross Margin %(computed) | 32.84% | 30.60% | 34.61% | 39.04% | 48.42% |
| Operating Expenses | |||||
| R&D Expenses | $0.60M | $0.93M | $1.86M | $0.81M | $0.67M |
| G&A Expenses | $18.48M | $14.00M | $10.10M | $8.90M | $1.87M |
| Total Operating Expenses | $16.40M | $16.48M | $13.12M | $10.37M | $2.55M |
| Operating Income | ($4.48M) | ($5.81M) | ($4.79M) | ($8.67M) | ($2.44M) |
| Operating Margin %(computed) | -12.34% | -16.67% | -19.86% | -199.60% | — |
| Interest Income | $0.28M | $0.50M | $0.81M | $0.52M | $0.00M |
| Interest Expense | $0.00M | $0.01M | $0.14M | $0.04M | $0.33M |
| Income Before Tax | ($5.95M) | ($5.37M) | ($4.11M) | ($26.51M) | ($12.44M) |
| Income Tax Expense | $0.02M | ($0.23M) | $0.40M | $0.23M | $0.00M |
| Net Income | ($5.98M) | ($5.13M) | ($4.51M) | ($26.74M) | ($12.44M) |
| Net Margin %(computed) | -16.46% | -14.72% | -18.70% | -615.44% | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-14.40 | $-73.20 | $-3513.60 | $-35236.40 | $-97743.20 |
| Wtd Avg Shares | 0.42M | 0.07M | 0.00M | 0.00M | 0.00M |
| EBITDA | ($4.15M) | ($5.14M) | ($3.82M) | ($26.45M) | ($12.09M) |
| EBITDA Margin %(computed) | -11.42% | -14.73% | -15.87% | -608.58% | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more Sunshine Biopharma, Inc. data
About Sunshine Biopharma, Inc. (SBFM) Income Statement
Sunshine Biopharma, Inc. (SBFM) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, SBFM reported revenue of $0.04B, gross profit of $0.01B (gross margin 32.84%), and net income of ($0.01B) — a net profit margin of -16.46%.
Frequently asked questions
SBFM · 4 questionsSunshine Biopharma, Inc. (SBFM) reported revenue of $0.04B for 2025, up 4.1% year-over-year.
SBFM revenueSBFM salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09